Skip to content

Acclinate vs Ancora.ai

Acclinate logo

Acclinate

Empowering Communities to Take Actions for Better Health

60 employees · est. 2020 · Birmingham, United States

VS
Ancora.ai logo

Ancora.ai

Ancora.ai is a patient-first, digital clinical trial navigation tool connecting cancer patients to clinical trials

9 employees · est. 2017 · Zurich, Switzerland

Ancora.ai is the older company (2020 vs 2017); Acclinate is the larger of the two.

Side-by-Side Comparison

Acclinate Ancora.ai
Founded
2020 2017 older
Headquarters
Birmingham, United States Zurich, Switzerland
Employees
60 larger 9
Industry
Biopharma, Health Care, Pharmaceutical AI, Big Data, Health Care
Funding Stage
Series A Grant
Total Funding
$12.09M $465.00K
Funding Rounds
5 6
Services
Community-driven recruitment, AI-powered clinical trial solutions, Predictive enrollment intelligence, Culturally relevant engagement Not tracked yet
Target Customers
Pharmaceutical Companies, Contract Research Organizations (CROs), Healthcare Communities, Underrepresented Populations in Clinical Trials Not tracked yet
Taxonomy
Health TechClinical Trial DiversityAI/ML TechnologyHealth EquityPersonalized MedicinePrecision Medicine +8 AI-drivenDigital Clinical TrialsPrecision MedicinePatient CentricityHealth EquityOncology +6
Website
acclinate.com ancora.ai
Acclinate logo

About Acclinate

Acclinate, founded in 2020, is a dynamic company at the intersection of Biopharma, Health Care, and Pharmaceuticals, headquartered in the United States. With a mission encapsulated in their slogan, "Empowering Communities to Take Actions for Better Health", Acclinate leverages cutting-edge technolog...

Ancora.ai logo

About Ancora.ai

Ancora.ai is a Switzerland-based startup with a vision to revolutionize cancer patient care by providing access to clinical research through their patient-first, digital clinical trials hub. Their precision medicine trial matching technology personalizes trial results for cancer patients in minutes,...

Also comparing in this category

Comparing more than these two?

Get Acclinate, Ancora.ai and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Acclinate compare?

A PDF of Acclinate and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Acclinate was founded in 2020, based in Birmingham, United States, with 60 employees. Acclinate, founded in 2020, is a dynamic company at the intersection of Biopharma, Health Care, and Pharmaceuticals, headquartered in the United States. With a mission encapsulated in their slogan, "E. Ancora.ai was founded in 2017, based in Zurich, Switzerland, with 9 employees. Ancora.ai is a Switzerland-based startup with a vision to revolutionize cancer patient care by providing access to clinical research through their patient-first, digital clinical trials hub. Their pre.
Acclinate has raised $12.09M and Ancora.ai $465.00K. Latest stage: Acclinate Series A, Ancora.ai Grant.
Both work in Health Care and Pharmaceutical and list health equity, personalized medicine and precision medicine among their focus areas.

Compare Acclinate with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Acclinate on 4 Jun 2026, and Ancora.ai on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout